RESEARCH TRIANGLE PARK, N.C., May 25 /PRNewswire/ -- Max Neeman International, a full service Contract Research Organization announces set-up of company central lab services beginning with a Phase II study in Oncology. The India-based CRO will be responsible for carrying out all the tests in this trial ranging from the easiest to the most complicated: serum cytokine analysis, peripheral T cell assays, immunocytohistochemistry, HLA typing, etc. The lab is NABL 15189:2007 / NABH accredited with state of the art equipment located in a Max Healthcare hospital.
Max Neeman services now include a wide-range of Central Lab capabilities for multicenter trials across various therapeutic segments. "We believe in continually expanding our service list and will continue to work closely with existing Central Lab partners to provide accurate results in the shortest possible turn around time. Central Lab services provided will be based on the best 'fit' for each study," said CEO, Dr. Ajoy Kumar.
Central Lab services include:
- Intraoperative cytology/frozen section
- Flow Cytometry
- Clinical Pathology
About Max Healthcare
With over 800 beds, 12 hospitals, 1500 physicians and 3000 support staff - Max Healthcare is one of a leading chain of hospitals in India. Its state of the art infrastructure, over 225 ICU beds and most advanced technologies makes it one of the best hospitals in India. For more information visit www.maxhealthcare.in.
About Max Neeman International
Max Neeman International is one of the leading and largest CROs in India. Our specialty is that we offer services for the successful conduct of Phase I-IV clinical and device trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2008 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in 22 cities with 6 regional offices. Contact Donald Swankie, Vice President of Business Development via email to firstname.lastname@example.org or call +1.919.424.3345. For more information visit www.neeman-medical.com.
SOURCE Max Neeman International